We’re currently upgrading our membership platform to bring you an improved experience. During this transition, access to member accounts is temporarily unavailable. We appreciate your patience and can’t wait to share the new and improved system with you soon!
For urgent membership questions, please contact info@clpsychiatry.org.
Journal Article Annotations
2025, 2nd Quarter
Annotations by Natalie Fedotova, MD, PhD
July, 2025
The finding:
In this systematic review of prospective observational studies and randomized controlled trials (RCTs), dyspnea was reported in over 40% of communicative mechanically ventilated (MV) adult patients and was more likely to be described as “air hunger”. On average, dyspnea was moderate to severe and varied in intensity and prevalence based on the scale used and the time of evaluation, with increases over the course of SBTs. Dyspnea was associated with anxiety, pain, depression, and higher likelihood of PTSD. Several strategies were suggested to reduce dyspnea in communicative and non-communicative MV patients, from optimization of ventilator settings to fan and music therapy.
Strength and weaknesses:
This systematic review included several recent studies and new data from corresponding authors. On the other hand, characterization of prevalence and severity of dyspnea excluded retrospective studies and non-communicative patients, whose distress is more likely to be underestimated. In addition, the authors did not discuss the quality of evidence for various interventions.
Relevance:
This review adds to the growing recognition that significant dyspnea in MV patients is common and underestimated, despite its association with extreme suffering and delays in progression of care, such as MV weaning. The combination of fear of death linked to breathlessness and the experience of helplessness, exacerbated by barriers to communication, creates the conditions for traumatization. CL psychiatrists are uniquely situated to advocate for consistent assessment and management of dyspnea and associated psychiatric symptoms in the ICU and beyond. Further work is needed to develop clinical guidelines and effective evidence-based interventions, though promising directions exist. See Sher et al (2024, PMID: 37952697) for an excellent review of dyspnea and dyspnea-related anxiety in the ICU and Demoule et al (2024, PMID: 38388984) for a relatively recent statement endorsed by the European Respiratory Society and the European Society of Intensive Care Medicine.